44 studies found for:    Open Studies | "Pruritus"
Show Display Options
Rank Status Study
21 Recruiting Efficacy Study of Two Choices of Phototherapy on Itching Skin Diseases
Conditions: Eczema;   Psoriasis
Interventions: Device: UVA / UVB phototherapy;   Device: UVB phototherapy
22 Not yet recruiting Efficacy of Calmmax Cream in the Management of Chronic Uremic Pruritus
Condition: Calmmax Cream on UP in CKD Patients.
Interventions: Drug: Callmax cream application over affected skin;   Drug: Placebo
23 Unknown  Demonstrate the Therapeutic Clinical Equivalence of Two Mometasone Nasal Sprays
Conditions: Nasal Obstruction;   Sneezing;   Itching
Intervention: Drug: Mometasone furoate
24 Unknown  Cyanobacteria Allergy in Lake Kineret
Conditions: Nasal Stuffiness;   Sneezing;   Itching
Intervention: Procedure: Skin test with sterile extracts of different cyanobacteria
25 Recruiting Hypnosis for Pain and Itch Following Burn Injuries
Condition: Burns
Interventions: Behavioral: Hypnosis;   Other: Standard of Care
26 Recruiting The Use of Botulinum Toxin in the Treatment of Itching From Hypertrophic Scar -- A Randomised Controlled Trial
Conditions: Itchiness;   Hypertrophic Scar;   Botulinum Toxin
Interventions: Drug: Botulinum Toxins;   Drug: Placebo
27 Unknown  Once a Day Topical Treatment for Athlete's Foot Fungus Inbetween the Toes in Males and Females
Conditions: Tinea Pedis;   Athlete's Foot;   Foot Fungus;   Ringworm
Intervention: Drug: Sertaconazole nitrate cream 2%
28 Recruiting Bleach Bath Treatment of Adults With Atopic Dermatitis
Condition: Atopic Dermatitis
Intervention: Drug: bleach bath (sodium hypochlorite)
29 Not yet recruiting Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis
Condition: Tinea Pedis
Interventions: Drug: Dapaconazole;   Drug: Ketoconazole
30 Recruiting Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Subjects With Tinea Pedis and Tinea Cruris
Conditions: Tinea Pedis;   Tinea Cruris
Intervention: Drug: Omeprazole 40mg
31 Unknown  Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections
Conditions: Fungal Infections;   Tinea Pedis;   Tinea Cruris;   Tinea Corporis
Intervention: Drug: Clotrimazole
32 Unknown  Safety and Efficacy of a Novel Topical Therapy for Tinea Pedis (Athlete's Foot)
Condition: Tinea Pedis
Intervention: Drug: Topical therapy
33 Unknown  Spread of Dermatophytes Among Families
Conditions: Onychomycosis;   Tinea Pedis
34 Not yet recruiting Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea
Condition: Conjunctivitis, Allergic
Intervention: Drug: Alcaftadine Ophthalmic Solution 0.25%
35 Recruiting To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
Condition: Atopic Dermatitis
Interventions: Drug: Tacrolimus Ointment 0.1%;   Drug: Protopic® ointment, 0.1%;   Drug: Placebo of Tacrolimus Ointment
36 Recruiting Neurobiology of the Scalp in Seborrheic Dermatitis
Condition: Seborrheic Dermatitis
Intervention: Procedure: Biopsy
37 Recruiting Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
Condition: Arthritis, Psoriatic
Intervention: Drug: Tofacitinib
38 Unknown  A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Placebo in the Treatment of Patients With Smouldering Systemic, Indolent Systemic or Cutaneous Mastocytosis With Handicap
Conditions: Smouldering Systemic Mastocytosis;   Indolent Systemic Mastocytosis;   Cutaneous Mastocytosis With Handicap;   Mastocytosis
Interventions: Drug: masitinib (AB1010);   Drug: placebo
39 Unknown  Probiotics in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: Probiotics
40 Not yet recruiting Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis
Conditions: Prurigo Nodularis;   Nodularis Prurigo;   Prurigo
Interventions: Drug: nalbuphine HCl ER 90 mg BID;   Drug: nalbuphine HCl ER 120 mg BID;   Drug: nalbuphine HCl ER 180 mg BID

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-44) Show next page of results    Last Page
Indicates status has not been verified in more than two years